IDO1 and cancer: A group of ICPs, including but not limited to PD-1/PD-L1, CTLA-4, lymphocyte activation 3 (LAG-3), TIM-3, VISTA, and indoleamine 2,3-dioxygenase 1 (IDO1), are shown to be dysregulated in cancer and infectious diseases.